Evidence map›Paper›PMID 35755074›Full record

ArticleFrontiers in medicine2022

Disqualification of Donor and Recipient Candidates From the Living Kidney Donation Program: Experience of a Single-Center in Germany.

Melissa Grigorescu, Stephan Kemmner, Ulf Schönermarck, Isidora Sajin, Wolfgang Guenther, Tiago Lemos Cerqueira, Ben Illigens, Timo Siepmann, Bruno Meiser, Markus Guba and 2 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Melissa GrigorescuDivision of Nephrology, Department of Internal Medicine IV, University Hospital Munich, Ludwig-Maximilians University (LMU), Munich, Germany.
Stephan KemmnerTransplant Center, University Hospital of Munich, Ludwig-Maximilians University (LMU), Munich, Germany.
Ulf SchönermarckDivision of Nephrology, Department of Internal Medicine IV, University Hospital Munich, Ludwig-Maximilians University (LMU), Munich, Germany.
Isidora SajinTransplant Center, University Hospital of Munich, Ludwig-Maximilians University (LMU), Munich, Germany.
Wolfgang GuentherTransplant Center, University Hospital of Munich, Ludwig-Maximilians University (LMU), Munich, Germany.
Tiago Lemos CerqueiraGerman Sites Development Principles and Practice of Clinical Research Harvard T.H., Chan School of Public Health, Dresden International University, Dresden, Germany.
Ben IlligensGerman Sites Development Principles and Practice of Clinical Research Harvard T.H., Chan School of Public Health, Dresden International University, Dresden, Germany.
Timo SiepmannGerman Sites Development Principles and Practice of Clinical Research Harvard T.H., Chan School of Public Health, Dresden International University, Dresden, Germany.
Bruno MeiserTransplant Center, University Hospital of Munich, Ludwig-Maximilians University (LMU), Munich, Germany.
Markus GubaTransplant Center, University Hospital of Munich, Ludwig-Maximilians University (LMU), Munich, Germany.
Michael FischerederDivision of Nephrology, Department of Internal Medicine IV, University Hospital Munich, Ludwig-Maximilians University (LMU), Munich, Germany.
Manfred Johannes StangTransplant Center, University Hospital of Munich, Ludwig-Maximilians University (LMU), Munich, Germany.
Ludwig-Maximilians-Universität München · DEDresden International University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Kidney transplantation is the best treatment option for patients with end-stage kidney disease (ESKD) with a superiority of graft survival after living kidney donation (LKD) compared to deceased donation. However, a large part of potential donors and recipients are ineligible for LKD. Here, we analyze the leading causes for disqualification of potential living donor-recipient pairs from the LKD program and the health-related consequences for ESKD patients excluded from the LKD program in a German transplant center. Methods: In this single-center retrospective cohort study we evaluated all candidates (potential donors and recipients) presenting for assessment of LKD from 2012 to 2020 at our transplant center. Thereby we focused on candidates excluded from the LKD program. Main reasons for disqualification were categorized as medical (donor-related), psychosocial, immunological, recipient-related, and unknown. Results: Overall, 601 donor-recipient pairs were referred to our transplant center for LKD assessment during the observation time. Out of those, 326 (54.2%) discontinued the program with 52 (8.7%) dropouts and 274 (45.6%) donor-recipient pairs being ineligible for LKD. Donor-related medical contraindications were the main reason for disqualification [139 out of 274 (50.7%) potential donors] followed by recipient-related contraindications [60 out of 274 (21.9%) of potential donor-recipient pairs]. Only 77 out of 257 (29.9%) potential recipients excluded from the LKD program received a kidney transplant afterward with a median waiting time of 2 (IQR: 1.0-4.0) years. Overall, 18 (7.0%) ESKD patients initially declined for LKD died in this period. Conclusion: A large percentage of donor-recipient pairs are disqualified from the German LKD program, mostly due to medical reasons related to the donor and with partly severe consequences for the potential recipients. For these, alternative solutions that promptly enable kidney transplantation are essential for improving patient quality of life and survival.

Indexed as

disqualification living kidney donorsend-stage kidney diseasekidney transplantationliving donor candidatesliving kidney donation

Identifiers

PMID35755074
PMCPMC9226311
OpenAlexW4281996590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.